These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 11808458)

  • 1. [Therapeutic recommendation in acute suppurative sinusitis. Antibiotic plus topical steroid].
    MMW Fortschr Med; 2001 Dec; 143(49-50):57. PubMed ID: 11808458
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment mostly not in line with current knowledge. New guidelines for sinusitis therapy].
    MMW Fortschr Med; 2004 Jun; 146(24):51. PubMed ID: 15366497
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of mometasone furoate nasal spray as an adjunct treatment of acute sinusitis.
    Chowdhury BA; Meyer RJ
    J Allergy Clin Immunol; 2001 Jul; 108(1):148-9. PubMed ID: 11447403
    [No Abstract]   [Full Text] [Related]  

  • 4. [Efficacy and safety of mometasone furoate nasal spray in the treatment of sinusitis or acute rhinosinusitis].
    Klossek JM
    Rev Laryngol Otol Rhinol (Bord); 2007; 128(3):187-92. PubMed ID: 18323331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is mometasone furoate aqueous nasal spray (MFNS) effective in reducing symptoms in acute recurrent sinusitis?
    McConaghy JR
    J Fam Pract; 2001 Feb; 50(2):107. PubMed ID: 11219553
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of mometasone furoate nasal spray in the treatment of chronic rhinosinusitis.
    Mösges R; Bachert C; Rudack C; Hauswald B; Klimek L; Spaeth J; Rasp G; Vent J; Hörmann K
    Adv Ther; 2011 Mar; 28(3):238-49. PubMed ID: 21318604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tazarotene 0.1% gel in combination with mometasone furoate cream in plaque psoriasis: a photographic tracking study.
    Poulin YP
    Cutis; 1999 Jan; 63(1):41-8. PubMed ID: 9951595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective comparison of acute rhinosinusitis outcomes in patients prescribed antibiotics, mometasone furoate nasal spray, or both.
    de Moor C; Reardon G; McLaughlin J; Maiese EM; Navaratnam P
    Am J Rhinol Allergy; 2012; 26(4):308-14. PubMed ID: 22801020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RESOLVE: a randomized, controlled, blinded study of bioabsorbable steroid-eluting sinus implants for in-office treatment of recurrent sinonasal polyposis.
    Han JK; Forwith KD; Smith TL; Kern RC; Brown WJ; Miller SK; Ow RA; Poetker DM; Karanfilov B; Matheny KE; Stambaugh J; Gawlicka AK
    Int Forum Allergy Rhinol; 2014 Nov; 4(11):861-70. PubMed ID: 25266981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PROPEL™ steroid-releasing bioabsorbable implant to improve outcomes of sinus surgery.
    Kennedy DW
    Expert Rev Respir Med; 2012 Nov; 6(5):493-8. PubMed ID: 23134241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intranasal steroid therapy in inflammatory nasal-sinus pathology in pediatric age].
    Berlucchi M; Tomenzoli D
    Minerva Pediatr; 2009 Jun; 61(3):323-31. PubMed ID: 19461575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mometasone furoate 0.1% and salicylic acid 5% vs. mometasone furoate 0.1% as sequential local therapy in psoriasis vulgaris.
    Tiplica GS; Salavastru CM
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):905-12. PubMed ID: 19470062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodality topical therapy for refractory chronic rhinosinusitis: our experience in thirteen patients with and twelve patients without nasal polyps.
    Shikani AH; Kourelis K; Alqudah MA; Shikani HJ; Cope E; Kirk N; Bergstedt D; Basaraba RJ; Leid JG
    Clin Otolaryngol; 2013 Jun; 38(3):254-8. PubMed ID: 23398898
    [No Abstract]   [Full Text] [Related]  

  • 14. In vivo assessment of the atrophogenic potency of mometasone furoate, a newly developed chlorinated potent topical glucocorticoid as compared to other topical glucocorticoids old and new.
    Kerscher MJ; Hart H; Korting HC; Stalleicken D
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):187-9. PubMed ID: 7620686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressive effects of topical mometasone furoate and tacrolimus on skin prick testing in children.
    Gradman J; Wolthers OD
    Pediatr Dermatol; 2008; 25(2):269-70. PubMed ID: 18429800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mometasone furoate nasal spray increases the number of minimal-symptom days in patients with acute rhinosinusitis.
    Meltzer EO; Gates D; Bachert C
    Ann Allergy Asthma Immunol; 2012 Apr; 108(4):275-9. PubMed ID: 22469449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis.
    Anolik R;
    Ann Allergy Asthma Immunol; 2008 Mar; 100(3):264-71. PubMed ID: 18426147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of mometasone 0.1% and salicylic acid 5% versus mometasone 0.1% on histamine wheal suppression.
    Achampat L; Rai R; Srinivas CR
    Indian J Dermatol Venereol Leprol; 2010; 76(6):724. PubMed ID: 21079336
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of cephalosporins.
    Goodwin CS
    Aust Fam Physician; 1979 Oct; 8(10):1113-7. PubMed ID: 518404
    [No Abstract]   [Full Text] [Related]  

  • 20. An open label study to compare the efficacy of topical mometasone furoate with topical placental extract versus topical mometasone furoate with topical tacrolimus in patients with vitiligo involving less than 10% body surface area.
    Shrestha S; Jha AK; Thapa DP; Bhattarai CK; Ghimire A
    Nepal Med Coll J; 2014 Sep; 16(1):1-4. PubMed ID: 25799800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.